To elucidate the developmental changes of atrial natriuretic polypeptide in the human heart, we studied \g=a\-humanatrial natriuretic polypeptide (\g=a\-hANP)-likeimmunoreactivity (\g=a-hANP-LI) in the extracts from the hearts of three foetuses of 10, 14 and 22 weeks' gestation, a 1-day-old premature infant of 33 weeks' gestation, and two adults. \g=a\-hANP-LIlevels in the atria of the three foetuses of 10, 14 and 22 weeks' gestation and the premature infant (31.4, 12.2, 9.25 and 15.3 nmol/g, respectively) were comparable to those in two adult atria (16.9 and 13.6 nmol/g). The ventricles also contained \g=a\-hANP-LI (0.763 \ar=r\0.0818 nmol/g with Lancet 2: 66-69.
descending values with increasing gestational age) in the three foetuses and the premature infant although it was undetectable (< 0.0162 nmol/g) in two adult ventricles. The highest \g=a\-hANP-LIconcentration was observed in the auricles in all the hearts except in the premature infant. The concentration in the right auricle was higher than in the left during foetal life, whereas that in the left was the higher one after birth. High performance gel permeation chromatography coupled with radioimmunoassay revealed that \g=a\-hANP\x=req-\ LI in the atria and apexes of the foetuses and the premature infant consisted of \g=a\hANP,\g=b\-hANP and \g=a\-hANP,with \g=g\-hANPbeing the predominant form. Essentially similar gel filtration patterns were observed in the two adult atria. These results indicate that: 1) ANP appears in human heart tissue early in foetal life;
2) cardiac ventricles also contain ANP in the foetus, and 3) there is probably no difference in posttranslational processing of the precursor molecule in foetal and adult hearts.
Mammalian atrial cardiocytes have been shown to contain multiple forms of atrial natriuretic poly¬ peptide (ANP) with potent diuretic, natriuretic and vasorelaxant activities (de Bold et al. 1981; Flynn et al. 1983; Kangawa & Matsuo 1984; Currie et al. 1984; Misono et al. 1984; Seidah et al. 1984 ; Atlas et al. 1984; Kangawa et al. 1985) , associated with atrial specific granules that show morphological resemblance to secretory granules observed in peptide hormone-producing cells (Kisch 1956; Jamieson & Palade 1964; de Bold 1979) . Recently, using a radioimmunoassay (RIA) for both -human ANP (ct-hANP) and -rat ANP (a-rANP), we reported the presence of large amounts of a-ANP-like immunoreactivity (a-ANP-LI) of three different molecular weight forms, -, ß-ANP and -, in the human and rat atria (Nakao et al. 1984; Sugawara et al. 1985a ). Also, we showed that a-hANP, a small molecular weight form of these peptides, is se¬ creted via the coronary sinus into peripheral blood and circulates in the body (Sugawara et al. 1985a ). Plasma a-hANP levels were reported to be elevated in patients with some congenital heart diseases (Lang et al. 1985) , congestive heart fail¬ ure (Tikkanen et al. 1985; Burnett et al. 1986 ), and hypertension (Sugawara et al. 1985b ). More¬ over, it was found that iv injection of synthetic a-hANP induces rapid and potent diuretic, natri-uretic and hypotensive responses in man (Tikkanen et al. 1985; Richards et al. 1985) . These results indicate that the heart is an endocrine organ as well as a pump organ. Jamieson & Palade (1964) and Bencosme & Berger (1971) reported that atrial specific gran¬ ules, associated with ANP, were not present in rat embryonic atria before the 10 mm stage. In the present study we examined a-hANP-LI in foetal, neonatal and adult human hearts to elucidate the developmental changes in human cardiac ANP.
Materials and Methods

Tissues
Two foetal hearts were obtained from legal abortions at 10 and 14 weeks of gestation. Informed consent was obtained from the parents. Four other hearts from a foetus, gestational age 22 weeks with a weight of 450 g and a crown-rump length of 19.5 cm, a 1-day-old female premature infant, gestational age 33 weeks, with a birth weight of 1390 g and a crown-rump length of 30.8 cm, and two adult females aged 71 (Adult-1) and 68 (Adult-2) years were obtained at autopsy. As to the foetus with a gestational age of 22 weeks, the pregnancy was interrupted by an accidental event. The causes of death were cerebral haemorrhage, gastric cancer, and acute promyelocytic leukaemia in the premature infant, Adults-1 and 2, respectively. We could find no struc¬ tural abnormalities in these six subjects. The six hearts were removed within 5 h post mortem. After the blood had been washed out with cold physiological saline, the hearts were placed on ice and adhering connective tissue was removed. The hearts were carefully dissected on ice into several parts according to anatomical struc¬ ture and, whenever necessary, under a stereo-micro¬ scope. However, to avoid contamination from atrial tissues, two ventricles of the foetus of 10 weeks' gesta¬ tion and the premature infant were dissected perpendi¬ cularly to the long axis into three sections (apex and two non-apex sections) before dissecting the atria. The non-apex sections of the premature infant were further dissected into septal, right and left ventricular parts. The tissues were accurately and rapidly weighed (AE 163, Mettler Instrumente AC, Switzerland; with a reproducibility of 0.02 mg). The tissues were frozen on dry ice immediately after weighing, and then stored at -70°C until extraction.
Extraction procedure
Tissues were boiled for 5 min in 10 to 100 volumes of 1 mol/1 acetic acid containing 20 mmol/1 HC1 to inhibit intrinsic proteolytic activity and then homogenized with a polytron homogenizer as described by Kangawa & Matsuo (1984) . The homogenate was centrifuged at 15 000 x g for 30 min at 4°C and the supernatant was stored at -30°C until RIA.
Radioimmunoassay
The RIA for a-hANP was performed as described previously (Nakao et al. 1984 ). Carboxy-terminal frag¬ ment, a-hANP (17-28) was synthesized by a conven¬ tional solution method (Okamoto et Louis, USA) was used as the immunogen (Yoshimasa et al. 1982 ). -hANP was radioiodinated by the chloramine method (Yoshimasa et al. 1982; Hunter & Greenwood 1962) . The standard RIA buffer was 0.1 mol/1 phosphate buffer, pH 7.0, containing 0.5% gela¬ tin (Merk, München, FRG), 1 mmol/1 Na2EDTA, 0.2 mmol/1 cystine, 0.1% Triton X-100, and 0.01% merthiolate, and was used to dissolve all reagents. The RIA incubation mixture consisted of 100 µ of standard -hANP or sample, 100 µ of a final 1:9000 dilution of antiserum (CR-3), 100 µ of 125I-a-hANP (approxim¬ ately 5000 cpm) and 200 µ of the standard buffer. The mixture was incubated for 72 h at 4°C. Bound and free ligands were separated by adding 1.0 ml of a suspension of dextran-coated charcoal consisting of 300 mg of Norit SX Plus (Norit, Amersfoort, The Netherlands) and 30 mg of Dextran T-70 (Pharmacia, Uppsala, Sweden) in 0.05 mol/1 phosphate buffer (pH 7.4) con¬ taining 0.01% merthiolate. This RIA recognizes not only -hANP but also other peptides with NH2-terminal extension such as ß-hANP and y-hANP and shows cross-reactivities of 100% with -hANP and a-hANP (7-28), 0.09% with a-hANP (24-28) and 0.05% with a-hANP (1-6) on a molar basis. The minimal detect¬ able quantity of -hANP in this RIA was 0.0162 pmol/ tube and the intra-and inter-assay variations were 4.4% and 7.8%, respectively.
High performance gel permeation chromatography (HP-GPC) HP-GPC was performed on a TSK-GEL G2000 SW (Toyo Soda, Tokyo, Japan) column (7.5 x 600 mm) and eluted with 10 mmol/1 trifluoroacetic acid containing 0.2 mol/1 sodium chloride and 30% acetonitrile as solvent. The flow rate was 0.3 ml/min and the fraction volume was 0.36 ml. The elution positions of peptides were monitored by ultraviolet absorbance at 210 nm or by RIA.
Results
Serial dilutions of the extracts from the foetal atria and ventricles yielded competition curves in the RIA that were parallel to the a-hANP stand¬ ard curve as shown in Fig. 1 .
The concentrations and contents of ct-hANP-LI in the six hearts examined are presented in Table   1 . Considerable amounts of ct-hANP-LI were de¬ tected in the atrium of the foetus of 10 weeks' gestation. The concentrations in atria of the three foetuses and the premature infant were com¬ patible with those in the two adult atria. The ventricles also contained moderate amounts of 
The concentrations of a-hANP-like immunoreactivity in the atrium and three regions of the ventricle, dissected perpendicularly to the long axis.
-hANP-LI in the three foetuses and the prema¬ ture infant, although -hANP-LI was not detect¬ able in the two adult ventricles.
In the foetus of 10 weeks' gestation and the premature infant, Fig. 2 Gel filtration profiles of -hANP-like immunoreactivity in the extracts from the atria of three foetuses of 10 (A), 14 (B), and 22 (C) weeks' gestation, the atrium oí a premature infant of 33 weeks'gestation (D), the apexes of the foetus of 10 weeks' gestation (E), and the premature infant of 33 weeks' gestation (F), and the atria of two adults (Adult-1, G; Adult-2, H). Arrows denote the elution positions of a series of myoglobins of polypeptide molecular weight calibration kit (Pharmacia, Uppsala, Sweden), void volume (V0), total volume (Vt), and synthetic a-hANP. Regional distribution of ct-hANP-like immunoreactivity ( -hANP-LI) adults. The -hANP-LI concentrations in the atria did not vary with development (Table 1) . Table 2 gives the distribution of -hANP-LI in the atria. The highest concentration was observed in the auricle of all the hearts except in that of the premature infant. Moreover, the concentration of -hANP-LI in the right auricle was higher than in the left in the two foetuses of 14 and 22 weeks' gestation, respectively, whereas that in the left was the higher one in the premature infant and the two adults. Table 3 shows the distribution of -hANP-LI in the ventricles. There was no characteristic pattern of distribution among the right and left ventricles and septum. -hANP-LI was not detectable in any regions of the two adult ventricles. HP-GPC profiles of -hANP-LI in the extracts from the atria of three foetuses and the prema¬ ture infant, the apexes of the foetus of 10 weeks' gestation and the premature infant, and the atria of two adults are depicted in Fig. 3 . The recovery of -hANP-LI with HP-GPC was over 80%. As shown in Fig. 3A , -hANP-LI in the atrium of the Downloaded from Bioscientifica.com at 12/03/2018 05:51:11PM via free access foetus of 10 weeks' gestation consisted of three components that were considered to be -hANP, ß-hANP and -hANP. Among these, -hANP was the predominant form, accounting for 91% of -hANP-LI. Essentially similar gel filtration pat¬ terns were observed in the extracts from the atria of the two other foetuses and the premature infant, the apexes of the foetus of 10 weeks' gestation and the premature infant, and the atria of the two adults.
Discussion
In the present study using RIA and HP-GPC, we demonstrated that ANP exists in the atrium of a human foetus of 10 weeks' gestation (the eighth intrauterine week) at which time the ANP concen¬ tration is comparable to that in two adult atria. It is known that functional circulation begins by the fourth intrauterine week and that the fourchambered heart is fully developed by the eighth intrauterine week. Thus, ANP appears during the very early stages of cardiac development. Jamieson & Palade (1964) and Bencosme & Berger (1971) reported that the early rat foetus possessed no specific granules associated with ANP in the atrial fibres, whereas in late foetal and neonatal rats, the atrial muscle cells contained many speci¬ fic granules. The difference between these earlier observations and the present results may be due to differences in species and/or experimental me¬ thods.
We also show that the ventricles contain con¬ siderable amounts of -hANP-LI in three foetuses and a premature infant and that -hANP-LI is undetectable in two adult ventricles. Since the specific granules (Jamieson & (Nakao et al. 1984; Cantin et al. 1984) have not yet been detected in the mammalian ventricle, the origin of -hANP-LI in these ventricles is of great interest. The -hANP-LI in these ventricles cannot be accounted for by contamination from atrial tissues as shown in Fig. 2 . Neither is it accountable by -hANP-LI in blood, because the concentration in the ventricle is much higher than in plasma and because -hANP is the predominant form of a-hANP-LI in the ventricle, whereas -hANP is the predominant form in human plasma (Sugawara et al. 1985a ). Furthermore, we demonstrated that the concentrations of ANP in these ventricles progressively decreased with gestational age. It has been reported that ventricular cardiocytes of several mammalian species contained no specific granules, but that specific granules were present in the non-mammalian ventricular cardiocytes (Jamieson & Palade 1964; Bencosme & Berger 1971) . It is interesting that ANP is detected in human foetal and non-mammalian ventricular cardiocytes and disappears with advancing devel¬ opment. These results suggest that the ventricular cardiocytes per se can produce ANP in the human foetus.
Another important finding in the present study is that the concentration of ANP in the right auricle is higher than in the left during the foetal period, whereas that in the left is higher than that in the right after birth. Dramatic changes in haemodynamics occur when the foetal circulation adapts to the extrauterine environment; the pressure level in the left atrium is lower than in the right in the foetal circulation and becomes higher than in the right after birth. The changes in relative concentrations of ANP in the right and left auricles might be related to these changes in the right and left atrial pressures. It is well known that the ANP concentration in the right atrium is higher than in the left in the adult rat , and we have observed that in the rat heart, the concentration of ANP was higher in the right auricle heart than in the left (unpublished data). Cantin et al. (1979) carried out a compara¬ tive study of the specific granules in right and left atria of various animal species and reported that the number of atrial specific granules was greater in the right atria of rat and mouse and in the left atria of guinea pig, hamster, rabbit and cat. These findings suggest that the concentration of ANP in the auricle might be related not only to atrial pressure but also to species.
The other important finding in the present study is that there are no differences in the gel filtration patterns among a-hANP-LIs in the foetal atria and ventricle, the atrium and ventricle of a premature infant of 33 weeks' gestation, and the adult atria. This suggests similar posttranslational processing of the same precursor between the foetal and adult hearts.
Further research is required to elucidate the pathophysiological and physiological significance of ANP in the foetus, premature infant and neonate.
